Press releases
- Savara to Present at the Jefferies Global Healthcare Conference
- Savara Presented New Data on Autoimmune Pulmonary Alveolar Proteinosis (aPAP) at the American Thoracic Society (ATS) International Conference 2024
- Savara Announces New Employment Inducement Grant
- Savara Reports First Quarter 2024 Financial Results and Provides Business Update
- Savara to Present at the Citizens JMP Life Sciences Conference
- Savara to Present New Data on Autoimmune Pulmonary Alveolar Proteinosis (aPAP) at the American Thoracic Society (ATS) International Conference 2024
More ▼
Key statistics
As of last trade, Savara Inc (YB4P:DUS) traded at 3.60, 52.54% above the 52 week low of 2.36 set on Jun 26, 2023.
52-week range
Short selling activityProvided by S&P Global Market Intelligence
Open | 3.60 |
---|---|
High | 3.60 |
Low | 3.60 |
Bid | 3.60 |
Offer | 3.74 |
Previous close | 3.60 |
Average volume | 0.00 |
---|---|
Shares outstanding | 138.19m |
Free float | 130.41m |
P/E (TTM) | -- |
Market cap | 585.92m USD |
EPS (TTM) | -0.3848 USD |
Data delayed at least 15 minutes, as of Jun 10 2024 11:30 BST.
More ▼